Research Analysts’ Updated EPS Estimates for August, 11th (AAPL, ADSK, AGU, ALO, ALRN, AMPH, ANTH, ASPS, ASV, ATH)

Research Analysts’ updated eps estimates for Friday, August 11th:

Apple (NASDAQ:AAPL) had its buy rating reissued by analysts at Longbow Research. The firm currently has a $173.00 price target on the stock.

Autodesk (NASDAQ:ADSK) had its outperform rating reiterated by analysts at Sanford C. Bernstein. They currently have a $138.00 target price on the stock, up from their previous target price of $137.00.

Agrium (NYSE:AGU) (TSE:AGU) had its buy rating reissued by analysts at Stifel Nicolaus. The firm currently has a $116.00 price target on the stock, up from their previous price target of $107.00.

Alio Gold (NYSE:ALO) was upgraded by analysts at BMO Capital Markets from an underperform rating to a market perform rating.

Aileron Therap (NASDAQ:ALRN) had its buy rating reiterated by analysts at Canaccord Genuity. They currently have a $19.00 target price on the stock.

Amphastar Pharmaceuticals (NASDAQ:AMPH) had its buy rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $19.00 price target on the stock, down from their previous price target of $20.00.

Anthera Pharmaceuticals (NASDAQ:ANTH) had its hold rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $1.75 target price on the stock, down from their previous target price of $2.25.

Altisource Portfolio Solutions (NASDAQ:ASPS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $26.00 target price on the stock. According to Zacks, “Altisource Portfolio Solutions S.A., together with its subsidiaries, is engaged in provision of real estate mortgage portfolio management and related technology products, as well as asset recovery and customer relationship management services. The Company has three segments: Mortgage Services, Financial Services and Technology Products. Mortgage Services provides valuation, real estate sales, default processing services, property inspection and preservation services, homeowner outreach, closing and title services and knowledge process outsourcing services. Financial Services comprises the Company’s asset recovery management and customer relationship management offerings to the financial services, consumer products, telecommunications and utilities industries. Technology Products is engaged in the design, development and delivery of technology products and services to the mortgage industry. “

ASV Holdings (NYSE:ASV) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $9.50 target price on the stock. According to Zacks, “ASV Holdings Inc. is a designer and manufacturer of compact construction equipment which consists of loader and skid steer loader equipment. It operates primarily in North America, Australia and New Zealand. ASV Holdings Inc. is based in Grand Rapids, United States. “

Athene Holding (NYSE:ATH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Athene Holding Ltd. is a retirement services company. Its products and services include Fixed and fixed indexed annuity products, Reinsurance services offered to third-party annuity providers and Institutional products, such as funding agreements. Athene Holding Ltd. is based in Pembroke, Bermuda. “

Atkore International Group (NASDAQ:ATKR) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Atkore International Group Inc. manufactures and distributes electrical raceway products. It offers steel tubes and pipes, electrical conduit, armored wire and cable, cable trays, metal framing systems and building components. Atkore International Group Inc. is based in Harvey, Illinois. “

AveXis (NASDAQ:AVXS) had its buy rating reiterated by analysts at Jefferies Group LLC. They currently have a $108.00 target price on the stock, up from their previous target price of $92.00.

Boeing Company (The) (NYSE:BA) had its outperform rating reaffirmed by analysts at Sanford C. Bernstein. They currently have a $274.00 target price on the stock.

BioSpecifics Technologies Corp (NASDAQ:BSTC) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “BIOSPECIFICS TECHNOLOGIES is engaged in the business of producing and licensing, for sale by other, a U.S. Food and Drug Administration (FDA) approved enzyme derived from collagenase, named Collagenase ABC, and researching, developing and clinically testing additional products derived therefrom for potential use as pharmaceuticals. “

Baytex Energy Corp (NYSE:BTE) (TSE:BTE) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Baytex Energy Trust is a conventional oil and gas income trust focused on maintaining its production and asset base through internal property development and delivering consistent returns to its unitholders. “

Cascadian Therapeutics (NASDAQ:CASC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Cascadian Therapeutics, Inc. is a biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer. The company’s product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor which is in preclinical trial stage. Cascadian Therapeutics, Inc., formerly known as Oncothyreon Inc., is headquartered in Seattle, Washington. “

Coca-Cola European Partners PLC (NYSE:CCE) had its hold rating reiterated by analysts at Deutsche Bank AG. The firm currently has a $46.00 target price on the stock, up from their previous target price of $44.00.

ChemoCentryx (NASDAQ:CCXI) was downgraded by analysts at Zacks Investment Research from a buy rating to a sell rating. According to Zacks, “ChemoCentryx, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx, Inc. is headquartered in Mountain View, California. “

The Chefs’ Warehouse (NASDAQ:CHEF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $19.00 target price on the stock. According to Zacks, “Chefs’ Warehouse Holdings, LLC is a distributor of specialty food products in the United States. The Company is focused on serving the specific needs of chefs who own and/or operate restaurants, fine dining establishments, country clubs, hotels, caterers, culinary schools and specialty food stores. Its product portfolio includes artisan charcuterie, specialty cheeses, unique oils and vinegars, hormone-free protein, truffles, caviar, and chocolate. It also offers cooking oils, butter, eggs, milk, and flour. Chefs’ Warehouse Holdings, LLC is based in Ridgefield, Connecticut. “

Civitas Solutions (NYSE:CIVI) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Civitas Solutions, Inc. is a national network of local health and human services. It operates as a provider of an array of community-based services to adults and children with intellectual and developmental disabilities, brain and spinal cord injuries and other catastrophic injuries and illnesses, and to youth with emotional, behavioral and medically complex challenges, as well as their families. The Company serves governmental agencies, non-public payors, and not-for-profit organizations. Civitas Solutions, Inc. is based in Boston, Massachusetts. “

C&J Energy Services (NYSE:CJ) had its buy rating reissued by analysts at Citigroup Inc.. The firm currently has a $36.00 price target on the stock, down from their previous price target of $39.00.

NorthStar Asset Management Group (NYSE:CLNS) had its buy rating reiterated by analysts at FBR & Co. They currently have a $15.00 price target on the stock, down from their previous price target of $16.00.

Coach (NYSE:COH) had its buy rating reissued by analysts at UBS AG. They currently have a $55.00 target price on the stock.

Copa Holdings, (NYSE:CPA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Copa Holdings, through its Copa Airlines and AeroRepublica operating subsidiaries, is a leading Latin American provider of passenger and cargo service. Copa Airlines currently offers daily scheduled flights to destinations in countries like North, Central and South America and the Caribbean. “

Capitala Finance Corp. (NASDAQ:CPTA) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Capitala Finance Corp. is a business development company. The company invests primarily in traditional mezzanine, senior subordinated and unitranche debt, senior and second-lien loans and equity securities. Capitala Finance Corp. is headquartered in Charlotte, United States. “

Deere & (NYSE:DE) had its hold rating reissued by analysts at Deutsche Bank AG. They currently have a $139.00 price target on the stock, up from their previous price target of $135.00.

DXC Technology Company. (NYSE:DXC) had its hold rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $79.00 target price on the stock. The analysts wrote, “Foresi’s Take. DXC reported below-expectation top line results, with declining legacy revenues somewhat offset by continued solid growth in Digital (+13.4%). DXC revenues fell organically by high-single digits, but only by mid- single digits when accounting for a PPA adjustment. Management maintained expectations for FY18, with margins expected to ramp as the fiscal year progresses.””

El Paso Electric (NYSE:EE) had its hold rating reiterated by analysts at Jefferies Group LLC. They currently have a $56.00 target price on the stock, up from their previous target price of $55.00.

Bottomline Technologies (NASDAQ:EPAY) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $33.00 target price on the stock, up from their previous target price of $31.00.

Luxoft Holding (NYSE:LXFT) had its outperform rating reiterated by analysts at Cowen and Company. The firm currently has a $63.00 price target on the stock, down from their previous price target of $68.00.

Macy’s (NYSE:M) had its hold rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $21.00 target price on the stock, down from their previous target price of $24.00.

Noodles & (NASDAQ:NDLS) had its hold rating reiterated by analysts at Jefferies Group LLC. They currently have a $4.50 price target on the stock, down from their previous price target of $5.50.

Paylocity Holding Corporation (NASDAQ:PCTY) had its buy rating reaffirmed by analysts at Stifel Nicolaus. They currently have a $55.00 target price on the stock, up from their previous target price of $50.00.

Perrigo (NYSE:PRGO) had its hold rating reissued by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $71.00 price target on the stock, up from their previous price target of $69.00.

Selecta Biosciences (NASDAQ:SELB) had its buy rating reissued by analysts at Canaccord Genuity. Canaccord Genuity currently has a $25.00 target price on the stock. The analysts wrote, “We are particularly interested in data on antibodies to SEL-212, which we expect to be very clean; that is, we do not expect antibodies to SEL-212. Given the previous data that we have seen, we are expecting SEL-212 to continue positive development with strong ADA suppression and a highly tolerable safety profile.””

Snap (NYSE:SNAP) had its neutral rating reissued by analysts at Bank of America Corporation. They currently have a $17.00 price target on the stock, down from their previous price target of $20.00.

The Trade Desk (NASDAQ:TTD) had its buy rating reissued by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $60.00 price target on the stock, up from their previous price target of $57.00.

TherapeuticsMD (NASDAQ:TXMD) had its buy rating reissued by analysts at Jefferies Group LLC. They currently have a $15.00 target price on the stock.

Under Armour (NYSE:UA) had its buy rating reiterated by analysts at Jefferies Group LLC. The firm currently has a $28.00 target price on the stock.

Under Armour (NYSE:UAA) had its buy rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $28.00 target price on the stock.

UnitedHealth Group (NYSE:UNH) had its outperform rating reissued by analysts at Cowen and Company. Cowen and Company currently has a $220.00 price target on the stock, up from their previous price target of $175.00.

Virtusa (NASDAQ:VRTU) had its buy rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $37.00 price target on the stock. The analysts wrote, “Foresi’s Take. Quarterly top-line results were above expectations, while earnings were just below our expectations primarily due to non-operating income line items. Management raised FY18 revenue guidance, with EPS projections tightened. Margins are expected to improve in FY18, but by slightly less than prior projections (+160 bps from +170 bps).””